Globus Medical, Inc. Class A Common Stock (NY:GMED)

75.60 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

May 28, 2025

From Pomerantz LLP

Via GlobeNewswire

This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

May 27, 2025

Via Benzinga

This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗

May 27, 2025

Via Benzinga

Assessing Globus Medical: Insights From 4 Financial Analysts ↗

May 27, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

What Does the Market Think About Globus Medical? ↗

April 25, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

May 22, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

May 18, 2025

From Pomerantz LLP

Via GlobeNewswire

Globus Medical Announces $500 Million Share Repurchase Program

May 15, 2025

From Globus Medical

Via GlobeNewswire

GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock at a Reasonable Price ↗

May 14, 2025

GLOBUS MEDICAL (NYSE:GMED) offers strong growth potential at a reasonable valuation, backed by solid financial health. A closer look at its fundamentals suggests it could be a compelling pick for...

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED

May 13, 2025

From Pomerantz LLP

Via GlobeNewswire

Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

A Glimpse Into The Expert Outlook On Globus Medical Through 6 Analysts ↗

May 09, 2025

Via Benzinga

Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 09, 2025

Via Benzinga

Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

May 09, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

May 08, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 08, 2025

Via Benzinga

Globus Medical (NYSE:GMED) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops 17.1%

May 08, 2025

Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s...

Via StockStory

Globus Medical Reports First Quarter 2025 Results

May 08, 2025

From Globus Medical

Via GlobeNewswire

Earnings To Watch: Globus Medical (GMED) Reports Q1 Results Tomorrow

May 07, 2025

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

GLOBUS MEDICAL INC - A (NYSE:GMED) ↗

May 02, 2025

Globus Medical (NYSE:GMED) shows strong growth potential with solid fundamentals and a promising technical setup, making it a stock to watch for investors seeking high-growth opportunities.

Via Chartmill

Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?

April 25, 2025

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling return of 3.4%. However, the stock is beating the S&P 500’s 5.2% decline...

Via StockStory

Topics Stocks

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

April 21, 2025

Via Benzinga

While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable. ↗

April 21, 2025

Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued.

Via Chartmill

Globus Medical Schedules First Quarter Earnings Release and Conference Call

April 17, 2025

From Globus Medical

Via GlobeNewswire

Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years ↗

April 17, 2025

Via Benzinga

Breaking Down Globus Medical: 5 Analysts Share Their Views ↗

April 11, 2025

Via Benzinga

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

April 09, 2025

Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season.

Via StockStory

Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)

April 08, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical...

Via StockStory

Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks

April 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.